BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12915)

  • 1. A test of the concept of "underlying depressive illness" in the treatment of anxiety states.
    Walsh MR; Dunckley HG; Sinclair JM; Schiff AA
    Curr Med Res Opin; 1976; 4(5):340-5. PubMed ID: 12915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety states in family practice: an evaluation of the need for antidepressant as well as anxiolytic therapy.
    McGhie RL; O'Hara H; O'Hara J; Brodie NH; Dunckley HG; Schiff AA
    J Int Med Res; 1977; 5(5):354-8. PubMed ID: 21116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once daily administration of a fluphenazine/nortriptyline preparation in the treatment of mixed anxiety/depressive states.
    Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rodway AE; Valle-Jones JC; Schiff AA
    Curr Med Res Opin; 1976; 4(5):346-52. PubMed ID: 795608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline.
    Magnus RV; Schiff AA
    J Int Med Res; 1977; 5(2):109-13. PubMed ID: 873028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states.
    Bennie EH; Schiff AA
    Scott Med J; 1976 Oct; 21(4):204-9. PubMed ID: 793005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed anxiety/depressive illness in general practice. A therapeutic comparison of nomifensine with fluphenazine/nortriptyline.
    Valle-Jones JC; Craven JR; Wallis TD; Schiff AA
    Acta Psychiatr Scand; 1983 Dec; 68(6):494-500. PubMed ID: 6666645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline.
    Sinclair JM; Walsh MR; Valle-Jones JC; Schiff AA
    Age Ageing; 1975 Nov; 4(4):226-31. PubMed ID: 803187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study with a combination of fluphenazine and nortriptyline in 70 cases of anxiety-depressive neuroses].
    Pacini L; Filippini G
    Clin Ter; 1977 May; 81(4):325-31. PubMed ID: 328219
    [No Abstract]   [Full Text] [Related]  

  • 9. Anxiety/depression in elderly patients. A double-blind comparative study of fluphenazine/nortriptyline and promazine.
    Brodie NH; McGhie RL; O'Hara H; Valle-Jones JC; Schiff AA
    Practitioner; 1975 Nov; 215(1289):660-4. PubMed ID: 1105543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate and combined anxiolytic and anti-depressant treatment of mixed anxiety/depression. A double-blind, placebo controlled comparison. Sussex Clinical Trials Group.
    Acta Psychiatr Scand; 1985 Jul; 72(1):81-8. PubMed ID: 2863922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?
    Buysse DJ; Reynolds CF; Houck PR; Perel JM; Frank E; Begley AE; Mazumdar S; Kupfer DJ
    J Clin Psychiatry; 1997 Oct; 58(10):426-32. PubMed ID: 9375592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of fluphenazine with nortriptyline in anxiety and depression.
    Anderson J; Lambert NG; Pigott PV
    Practitioner; 1972 Apr; 208(246):511-7. PubMed ID: 4555519
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of clinical studies with combinations of fluphenazine and nortriptyline.
    Pigott PV
    Curr Med Res Opin; 1972; 1(1):26-36. PubMed ID: 4589400
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctor's versus patient's judgement in the assessment of mixed anxiety/depressive illness. Implications for measurement of therapeutic response.
    Valle-Jones JC; O'Hara J; O'Hara H; McGhie RL; Brodie NH; Anderson JA; Schiff AA
    Acta Psychiatr Scand; 1981 May; 63(5):416-24. PubMed ID: 7032221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anxious-depressive syndrome. Polycentric study with the collaboration of 1,048 Italian physicians].
    Maisto F
    Clin Ter; 1977 Jan; 80(1):49-65. PubMed ID: 862352
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
    Herrera-Arellano A; Jiménez-Ferrer JE; Zamilpa A; García-Alonso G; Herrera-Alvarez S; Tortoriello J
    Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
    Conway JF
    Practitioner; 1981 Mar; 225(1353):400-4. PubMed ID: 7022433
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.